CareDx Ownership | Who Owns CareDx?
CareDx Ownership Summary
CareDx is owned by 39.77% institutional investors, 3.40% insiders, and 56.83% retail investors. Blackrock is the largest institutional shareholder, holding 10.13% of CDNA shares. Bellevue Healthcare Ord is the top mutual fund, with 6.13% of its assets in CareDx shares.
CDNA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | CareDx | 39.77% | 3.40% | 56.83% |
| Sector | Healthcare Stocks | 35.49% | 11.78% | 52.72% |
| Industry | Diagnostics & Research Stocks | 50.92% | 10.77% | 38.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 5.29M | 10.13% | $82.10M |
| Blackrock funding, inc. /de | 4.52M | 8.85% | $78.50M |
| Vanguard group | 3.43M | 6.53% | $64.59M |
| Bamco inc /ny/ | 3.34M | 6.53% | $57.92M |
| State street | 2.76M | 5.40% | $47.92M |
| Ark investment management | 2.23M | 4.36% | $38.67M |
| Deerfield management company, l.p. (series c) | 2.19M | 4.29% | $38.04M |
| Braidwell lp | 2.17M | 4.25% | $37.73M |
| Boston partners | 1.88M | 3.68% | $32.71M |
| Gagnon securities | 1.76M | 3.45% | $30.59M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Blue water life science advisors, lp | 935.00K | 13.02% | $16.23M |
| Paragon associates & paragon associates ii joint venture | 500.00K | 11.80% | $8.68M |
| Gagnon securities | 1.76M | 7.06% | $30.59M |
| Gagnon advisors | 532.89K | 6.81% | $9.25M |
| Kent lake pr | 550.00K | 4.04% | $8.00M |
| Bullseye asset management | 220.49K | 2.22% | $3.83M |
| Ophir asset management pty | 988.05K | 2.00% | $17.15M |
| Palo alto investors lp | 531.87K | 1.41% | $9.23M |
| Braidwell lp | 2.17M | 1.26% | $37.73M |
| Zweig-dimenna associates | 390.25K | 0.94% | $6.77M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Boston partners | 1.88M | 0.03% | 981.61K |
| Braidwell lp | 2.17M | 1.26% | 587.93K |
| Kent lake pr | 550.00K | 4.04% | 550.00K |
| Blue water life science advisors, lp | 935.00K | 13.02% | 425.00K |
| Chevy chase trust | 1.50M | 0.08% | 422.73K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Hood river capital management | - | - | -1.77M |
| Next century growth investors | - | - | -1.13M |
| Citadel advisors | 84.17K | 0.00% | -558.59K |
| Point72 asset management | - | - | -465.67K |
| Macquarie group | - | - | -462.95K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Kent lake pr | 550.00K | 4.04% | 550.00K | $8.00M |
| Vanguard fiduciary trust | 352.47K | 0.00% | 352.47K | $6.12M |
| Meridiem capital partners lp | 316.95K | 0.36% | 316.95K | $5.50M |
| Vanguard asset management | 33.23K | 0.00% | 33.23K | $576.91K |
| Xtx topco | 27.72K | 0.01% | 27.72K | $481.22K |
Sold Out
| Holder | Change |
|---|---|
| Ronald blue trust | -1.00 |
| Turning point benefit group | -2.00 |
| Clearstead advisors | -6.00 |
| Parallel advisors | -9.00 |
| Nelson, van denburg & campbell wealth management group | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 86 | -57.21% | 20,332,625 | -61.02% | 39 | 0.40% | 47 | -54.81% | 23 | -64.06% |
| Dec 31, 2025 | 128 | -32.63% | 32,873,192 | -38.62% | 62 | 0.64% | 61 | -39.00% | 43 | -28.33% |
| Sep 30, 2025 | 126 | -33.33% | 32,579,838 | -35.97% | 59 | 0.68% | 67 | -24.72% | 41 | -36.92% |
| Jun 30, 2025 | 195 | -11.76% | 54,120,198 | -3.40% | 99 | 0.97% | 90 | -14.29% | 68 | -15.00% |
| Mar 31, 2025 | 219 | 3.30% | 55,979,533 | 5.60% | 101 | 1.01% | 104 | -20.61% | 79 | 58.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Bellevue Healthcare Ord | 3.23M | 6.13% | 3.23M |
| Baron Discovery Institutional | 2.39M | 4.67% | 123.80K |
| Baron Discovery Strategy | 2.39M | 4.67% | 123.80K |
| ARK Genomic Revolution | 2.11M | 4.12% | 65.94K |
| ARK Genomic Revolution ETF | 2.01M | 3.89% | 85.05K |
| State Street® SPDR® S&P® Biotech ETF | 1.63M | 3.16% | -16.30K |
| Vanguard Total Stock Mkt Idx Inv | 1.54M | 3.00% | - |
| Vanguard US Total Market Shares ETF | 1.52M | 2.74% | -168.20K |
| Amova ARK Pstv Chg Innovt P JPY Acc | 1.22M | 2.37% | -24.64K |
| iShares Russell 2000 ETF | 1.19M | 2.30% | 10.01K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 14, 2026 | TORRES ARTHUR A | - | Sell | $85.70K |
| May 15, 2026 | TORRES ARTHUR A | - | Sell | $128.98K |
| May 05, 2026 | Novack Jeffrey Adam | Secretary and General Counsel | Sell | $55.58K |
| Apr 16, 2026 | Hanna John Walter JR | President and CEO | Sell | $217.16K |
| Feb 03, 2026 | Novack Jeffrey Adam | Secretary and General Counsel | Sell | $91.29K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 2 |
| 2026 Q1 | - | 4 |
| 2025 Q4 | - | 3 |
| 2025 Q3 | - | 2 |
| 2025 Q2 | - | 10 |
CDNA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools